Brazilian court rules that growers will continue to have access to glyphosate
Monheim/St. Louis, September 3, 2018 – Bayer welcomes the ruling issued today by a Brazilian court that ensures growers in that country will have continued access to glyphosate-based herbicides.
“This ruling is very good news for Brazilian growers, who count on glyphosate-based herbicides to control weeds and grow their crops safely and effectively,” said Liam Condon, Member of the Board of Management of Bayer AG and President of the Crop Science Division. “Glyphosate helps farmers grow their crops with less of an impact on the soil and reduced carbon emissions.”
On August 3, 2018 a Brazilian judge issued an injunction that could have prohibited the registration and use of glyphosate-based herbicides and several other crop protection products in the country. The injunction was not a ruling on glyphosate safety but only related to delays in routine regulatory reviews of crop protection products.
On Monday, a Brazilian court ruled in favor of a remedy filed by the Federal Government to overturn the injunction before it took effect and ensure that Brazilian growers can continue to use glyphosate-based products.
Find more information at www.bayer.com.
Cautionary Statements Regarding Forward-Looking Information
Certain statements contained in this communication may constitute “forward-looking statements.” Actual results could differ materially from those projected or forecast in the forward-looking statements. The factors that could cause actual results to differ materially include the following: the risk that the parties may be unable to achieve expected synergies and operating efficiencies in the merger within the expected timeframes (or at all) and to successfully integrate the operations of Monsanto Company (“Monsanto”) into those of Bayer Aktiengesellschaft (“Bayer”); such integration may be more difficult, time-consuming or costly than expected; revenues following the transaction may be lower than expected; operating costs, customer loss and business disruption (including difficulties in maintaining relationships with employees, customers, clients or suppliers) may be greater or more significant than expected following the transaction; the retention of certain key employees at Monsanto; the parties’ ability to meet expectations regarding the accounting and tax treatments of the merger; the impact of refinancing the loans taken out for the transaction; the impact of indebtedness incurred by Bayer in connection with the transaction and the potential impact on Bayer’s rating of indebtedness; the effects of the business combination of Bayer and Monsanto, including the combined company’s future financial condition, operating results, strategy and plans; other factors detailed in Monsanto’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”) for the fiscal year ended August 31, 2017, and Monsanto’s other filings with the SEC, which are available at http://www.sec.gov and on Monsanto’s website at www.monsanto.com; and other factors discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. Bayer assumes no obligation to update the information in this communication, except as otherwise required by law. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof.